Antitrust Class Action Filed Against Merck for its Rotavirus Vaccine, RotaTeq

Merck, the New Jersey-based pharmaceutical company, was hit with an antitrust class action Friday in the Pennsylvania Eastern District Court over its rotavirus vaccine, RotaTeq. The complaint contends that Merck incentivized competitor GlaxoSmithKline to maintain high prices for its rotavirus vaccine instead of competing with Merck. The plaintiffs argue that this incentive caused less competitive pressure on Merck to reduce the pricing of RotaTeq. The class is represented by Berger Montague; Cohen Milstein Sellers & Toll; and the City of Baltimore Department of Law. Counsel have not yet appeared for the defendant. The case is 2:23-cv-00828, Mayor And City Council Of Baltimore v. Merck Sharp & Dohme Corp.

This suit was surfaced by Radar, a source for high-speed legal news and litigation updates personalized to your practice. Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be the first to know about new suits in your region, practice area or client sector. Read the complaint here:

Scroll to Top